Hypolipidemic and hypoglycemic effects of aerial part of cynara scolymus in streptozotocin-induced diabetic rats

Journal of Medicinal Plants Research

Volumn 5, Issue 13, 2011, Pages 2717-2723

  Heidarian, Esfandiar ^a   Soofiniya, Yadollah ^b  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PAYAME NOOR UNIVERSITY   (Iran)

Author keywords

Cynara scolymus; Diabetes; Hypoglycemic; Hypolipidemic; Lipid peroxidation; Superoxide dismutase

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CYNARA SCOLYMUS EXTRACT; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PLANT LEAF; RAT; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

CYNARA SCOLYMUS; RATTUS;

EID: 79961091144     PISSN: None     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bagri P, Ali M, Aeri V, Bhowmik M, Sultana S (2009). Antidiabetic effect of Punica granatum flowers: effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Food Chem. Toxicol., 47: 50-54.
2. Baydas G, Nedzvetskii VS, Nerush PA, Kirichenko SV, Yoldas T (2003). Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocininduced diabetes mellitus. Life Sci., 73: 1907-1916.
3. Benzie IF, Strain JJ (1996). The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal. Biochem., 239: 70-76.
4. Brown J, Rice EC (1998). Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro. Free Radic. Res., 29: 247-255.
5. Davi G, Falco A, Patrono C (2005). Lipid peroxidation in diabetes mellitus. Antioxid. Redox Signal., 7: 256-268.
6. Elisaf M, Bairaktari H, Tzaiallas C, Germanos N, Siamopoulos K (1995). Lipoprotein (a) concentration and serum albumin in haemodialysis patients. Dial. Transplant, 24: 642-650.
7. Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18: 499-502.
8. Gebhardt R (1997). Antioxidative and protective properties of extracts from leaves of the artichoke (Cynara scolymus L.) against hydroperoxide-induced oxidative stress in cultured rat hepatocytes. Toxicol. Appl. Pharmacol., 144: 279-286.
9. Gebhardt R (2002). Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pretreatment. Phytother. Res., 16: 368-372.
10. Goldberg RB (1981). Lipid disorders in diabetes. Diabetes Care, 4: 561-572.
11. Gupta S, Kataria M, Gupta PK, Murganandan S, Yashroy RC (2004). Protective role of extracts of neem seeds in diabetes caused by streptozotocin in rats. J. Ethnopharmacol., 90: 185-189.
12. Gylling H, Tuominen JA, Koivisto VA, Miettinen TA (2004). Cholesterol metabolism in type 1 diabetes. Diabetes, 53: 2217-2222.
13. Joy JF, Haber SL (2007). Clinical uses of artichoke leaf extract. Am. J. Health Syst. Pharm., 64: 1906-1909.
14. Kaleem M, Asif M, Ahmed Q, Bano B (2006). Antidiabetic and antioxidant activity of Annona squamosa extract in streptozotocininduced diabetic rats. Singapore Med. J., 47: 670-675.
15. Kameswara RB, Renuka SP, Rajasekhar MD, Nagaraju N, Appa RC (2003). Antidiabetic activity of Terminalia pallida fruit in alloxan induced diabetic rats. J. Ethnopharmacol., 85: 169-172.
16. Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, Kandhro GA (2008). Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol. Trace Elem. Res., 122: 1-18.
17. Lin Y, Tsai H, Lee Y, Chang S (2005). Maternal vitamin E supplementation affects the antioxidant capability and oxidative status of hatching chicks. J. Nutr., 135: 2457-2461.
18. Llorach R, Espin J, Tomas BF, Ferreres F (2002). Artichoke (Cynara scolymus L.) byproducts as a potential source of health-promoting antioxidant phenolics. J. Agric. Food Chem., 50: 3458-3464.
19. Maritim AC, Sanders RA, Watkins JB (2003). Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J. Nutr. Biochem., 14: 288-294.
20. Medina J, Moreno OR (2005). Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs, 65: 2445-2461.
21. Moon YS, Kashyap ML (2004). Pharmacologic treatment of type 2 diabetic dyslipidemia. Pharmacother., 24: 1692-1713.
22. Naziro LM, Butterworth P (2005). Protective effects of moderate exercise with dietary vitamin C and E on blood antioxidative defense mechanism in rats with streptozotocin-induced diabetes. Can. J. Appl. Physiol., 30: 172-185.
23. Nazni P, Vijayakumar T, Alagianambi P, Amirthaveni M (2006). Hypoglycemic and hypolipidemic effect of Cynara Scolymus among selected type 2 diabetic individuals. Pakistan J. Nutr., 5: 147-151.
24. Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95: 351-358.
25. Pérez GF, Adzet T, Caigueral S (2000). Activity of artichoke leaf extract on reactive oxygen species in human leukocytes. Free radic. Res., 33: 661-665.
26. Piedrola G, Novo E, Escobar F, Garcia RR (2001). White blood cell count and insulin resistance in patients with coronary artery disease. Ann. Endocrinol., 62: 7-10.
27. Pittler M, Thompson C, Ernst E (2002). Artichoke leaf extract for treating hypercholesterolaemia. Cochrane Database Syst. Rev. 3, CD003335.
28. Rang HP, Dale MM, Ritter JM (1991). The endocrine system pharmacology. In: Pharmacology. LongmanGroup Ltd, UK.
29. Rolo AP, Palmeira CM (2006). Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol., 212: 167-178.
30. Ros R, Assaloni R, Ceriello A (2004). Antioxidant therapy in diabetic complications: what is new? Curr. Vasc. Pharmacol., 2: 335-341.
31. Van DSY, Kreijkamp KS, Peeters P, Keinan BL, Rimm E, Grobbee D (2005). Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circ., 111: 465-471.
32. Vats V, Grover JK, Rathi SS (2002). Evaluation of anti-hyperglycemic and hypoglycemic effect of Trigonella foenum-graecum Linn, Ocimum sanctum Linn and Pterocarpus marsupium Linn in normal and alloxanized diabetic rats. J. Ethnopharmacol., 79: 95-100.
33. Vincent A, Russell J, Low P, Feldman E (2004). Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev., 25: 612-628.
34. Wang M, Simon JE, Aviles IF, He K, Zheng QY, Tadmor Y (2003). Analysis of antioxidative phenolic compounds in artichoke (Cynara scolymus L.). J. Agric. Food Chem., 51: 601-608.
35. Yadav P, Sarkar S, Bhatnagar D (1997). Action of capparis decidua against alloxan-induced oxidative stress and diabetes in rat tissues. Pharmacol. Res., 36: 221-228.
36. Yaryura TJ, Pinto A, Neziroglu F (2001). Anorexia nervosa, diabetes mellitus, brain atrophy, and fatty liver. Int. J. Eat. Disord., 30: 350-353.
37. Zapolska DD, Zapolski DA, Naruszewicz M, Siennicka A, Krasnodebska B, Koldziej B (2002). Protective properties of artichoke (Cynara scolymus) against oxidative stress induced in cultured endothelial cells and monocytes. Life Sci., 71: 2897-2908.